44.0% 136.1 143.6 7.5 5.5% Solar Engergy Power Plant 1.4 0.9 1.9 1.5 (0.4) (21.1%) 0.5 5.7 5.2 1,040.0% Gross Profit by Segment 427.9 446.0 463.1 454.3 (8.8) (1.9%) 1,625.9 1,791.3 165.4 10.2% Change QoQ
Liabilities was Baht 12,859.5 million, increased by Baht 3,135.5 million from Baht 9,724.0 million at year-end 2018 mainly due to increase of Current Portion of Long Term Liabilities Baht 4,123.1 million and
projects. The project detail is as followed: 1.) To repay the short-term liabilities and some portion of account payables as follow: 1.1) Some portion of not-related account payables of THB 30 mn 1.2) Short
not able to cover selling and administrations expenses of the Company. In addition, in 2017 the company had realized gain from debt restructuring by converting major portion of trade debts into equity
portion of trade debts into equity and gain form exchange rate which those non-cash revenues were high at Baht 1,045 million while this year the company has such non-cash gain only Baht 225 million. From
under rehabilitation plan and compromise 531,482 659,013 (19%) Current portion of long-term loan from related party 314,000 314,000 0% Current portion of bonds 479,569 505,934 (5%) Short-term loan from
outlets under “After You” and “Maygori” brand • Take-home product sales including customer purchases at branch and orders through food delivery services • Portion of In-store sales : Take home product sales
customers 185 192 (4%) Short-term loan from related parties 1,256 1,476 (15%) Accrued interest expenses 140 201 (30%) Current portion of liabilities under rehabilitation plan 199 204 (3%) Current portion of
institutions amounted Baht 35.9 million, and Short-term loans and Current portion of long-term borrowing from financial institutions amounted Baht 205.1 million . Net Interest-bearing Debt as of 3Q2019 was Baht
larger portion of the Heavy crude market share. Saudi Aramco announced discounts of its Official Selling Price (OSP) for crude oil delivered to customers in every country. Also pressure from the COVID-19